Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03693170 |
| Consolidated Lead Sponsor | Pierre Fabre Medicament |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 95 participants (ACTUAL) |
| Registered Start Date | 2019-01-17 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Memorial Sloan Kettering Cancer Center | New York, NY | Open Hospital Dossier -> |
| Cliniques Universitaires Saint-Luc | Brussels, Belgium | Open Hospital Dossier -> |
| Hôpital Saint-Antoine | Paris, France | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.